Early Molecular Response to Imatinib First-Line Therapy and Predictive Factors of Poor Outcomes for Chronic Myeloid Leukemia Patients in Côte d'Ivoire
2024

Early Response to Imatinib Therapy in Chronic Myeloid Leukemia Patients in Côte d'Ivoire

Sample size: 60 publication 10 minutes Evidence: moderate

Author Information

Author(s): Koffi Kouassi Gustave, Bognini Sara Akou, Silué Dohoma Alexis, Kamara Ismael, Kouakou Ines, N'dhatz Emeraude, Kouakou Boidy, Nanho Danho Clotaire, Okou David Tea

Primary Institution: Department of Hematology Teaching Hospital, Centre Hospitalier Universitaire de Yopougon, Ivory Coast

Hypothesis

The study aimed to evaluate the early molecular response to imatinib therapy and identify predictive factors for poor outcomes in chronic myeloid leukemia patients.

Conclusion

An early molecular response at 3 months can predict a deep molecular response in chronic myeloid leukemia patients treated with imatinib.

Supporting Evidence

  • 48% of patients achieved an optimal response with TKI therapy after 3 months.
  • 90% of patients with an optimal response at 3 months showed a deep molecular response.
  • Seven independent risk factors were identified that significantly influenced early molecular response.

Takeaway

This study shows that checking how well patients respond to imatinib after 3 months can help doctors know if they will do well with the treatment.

Methodology

60 newly diagnosed CML patients were treated with imatinib and their early molecular response was assessed using RT-qPCR at 3 months.

Potential Biases

Potential biases may arise from the limited sample size and the specific demographic of the study population.

Limitations

The study was limited to a single center in Côte d'Ivoire and may not be generalizable to other populations.

Participant Demographics

The median age of participants was 45 years, with 57% male and 43% female.

Statistical Information

P-Value

0.00001

Confidence Interval

95% CI: 1.186–10.108

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2024/4576455

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication